Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Hendriks

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|October 21, 1993
Flunarizine as a modulator of doxorubicin resistance in human colon-adenocarcinoma cellsR Silvestrini, N Zaffaroni, A Costa, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Cycloplatam: a novel platinum compound exhibiting a different spectrum of anti-tumour activity to cisplatinM Drees, W M Dengler, H R Hendriks, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 23, 2017
Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancerR M Phillips, H R Hendriks, J B Sweeney, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenograftsK Breistøl, H R Hendriks, D P Berger, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell linesA M Bergman, C M Kuiper, F Myhren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancerH R Hendriks, H H Fiebig, R Giavazzi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenograftsH R Hendriks, S Langdon, D P Berger, et al.
Biochemical Pharmacology|February 7, 1997
KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl]mitomycin C). A new mitomycin C analogue activated by serumJ R Masters, R J Know, J A Hartley, et al.
Journal of Medicinal Chemistry|June 21, 1996
Alkyl and alkoxyethyl antineoplastic phospholipidsM Koufaki, V Polychroniou, T Calogeropoulou, et al.
International Journal of Cancer|February 15, 1989
Anti-tumor and differentiation-inducing activity of N,N-dimethylformamide (DMF) in head-and-neck cancer xenograftsG A van Dongen, B J Braakhuis, A Leyva, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|October 21, 1993
Flunarizine as a modulator of doxorubicin resistance in human colon-adenocarcinoma cellsR Silvestrini, N Zaffaroni, A Costa, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Cycloplatam: a novel platinum compound exhibiting a different spectrum of anti-tumour activity to cisplatinM Drees, W M Dengler, H R Hendriks, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 23, 2017
Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancerR M Phillips, H R Hendriks, J B Sweeney, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenograftsK Breistøl, H R Hendriks, D P Berger, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell linesA M Bergman, C M Kuiper, F Myhren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancerH R Hendriks, H H Fiebig, R Giavazzi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenograftsH R Hendriks, S Langdon, D P Berger, et al.
Biochemical Pharmacology|February 7, 1997
KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl]mitomycin C). A new mitomycin C analogue activated by serumJ R Masters, R J Know, J A Hartley, et al.
Journal of Medicinal Chemistry|June 21, 1996
Alkyl and alkoxyethyl antineoplastic phospholipidsM Koufaki, V Polychroniou, T Calogeropoulou, et al.
International Journal of Cancer|February 15, 1989
Anti-tumor and differentiation-inducing activity of N,N-dimethylformamide (DMF) in head-and-neck cancer xenograftsG A van Dongen, B J Braakhuis, A Leyva, et al.
Pageof 4